P
Polung Yang
Researcher at Chang Gung University
Publications - 3
Citations - 47
Polung Yang is an academic researcher from Chang Gung University. The author has contributed to research in topics: Platelet activation & Platelet. The author has an hindex of 3, co-authored 3 publications receiving 31 citations.
Papers
More filters
Journal ArticleDOI
C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury.
Chiou-Mei Lee,Hsin-Hsin Peng,Hsin-Hsin Peng,Polung Yang,Jiin-Tarng Liou,Chia-Chih Liao,Yuan-Ji Day,Yuan-Ji Day +7 more
TL;DR: A sequence of early events elicited by CCL5 chemoattracting macrophage that result in inflammatory aggravation of hepatic IRI are demonstrated.
Journal ArticleDOI
The anti-aggregation effects of ondansetron on platelets involve IP3 signaling and MAP kinase pathway, but not 5-HT3-dependent pathway
Fu-Chao Liu,Jiin-Tarng Liou,Jiin-Tarng Liou,Hsiang-Ruei Liao,Chih-Chieh Mao,Chih-Chieh Mao,Polung Yang,Yuan-Ji Day,Yuan-Ji Day +8 more
TL;DR: The positive effect of ondansetron on platelet aggregation is manifested through the attenuation of agonist-induced IP3 production and MAPK (p38 and ERK2) phosphorylation that results in suppressed intracellular Ca(2+) mobilization, TXB2 formation, and ATP release.
Patent
Application and pharmaceutical composition of preactivated and disaggregated shape-changed platelets
Yuan-Ji Day,Li-Man Hung,Shiang-Suo Huang,Hsiang-Ruei Liao,Chiou-Mei Lee,Jiin-Tarng Liou,Fu-Chao Liu,Chih-Chieh Mao,Polung Yang +8 more
TL;DR: In this article, the authors used preactivated and disaggregated shape-changed platelets, fixed shape changed platelets and a pharmaceutical composition thereof for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108.